"Otorgamos tratamientos oncológicos innovadores a pacientes con distintos tipos de cáncer a través de estudios clínicos que buscan probar la eficacia y seguridad de nuevos tratamientos."

During the past decade, Centro Investigación del Cáncer James Lind ( Site 1041) conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro Investigación del Cáncer James Lind ( Site 1041)" are "Prostatic Neoplasms" (3 trials), "Chemotherapy-induced Thrombocytopenia" (1 trials), "Gastric Cancer" (1 trials) and "Gastroesophageal Junction Adenocarcinoma" (1 trials). Many other conditions were trialed in "Centro Investigación del Cáncer James Lind ( Site 1041)" in a lesser frequency.

Most popular intervention types in "Centro Investigación del Cáncer James Lind ( Site 1041)" are "Drug" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Pembrolizumab" (3 trials), "Enzalutamide" (2 trials), "Prednisone" (2 trials) and "Abiraterone acetate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Investigación del Cáncer James Lind ( Site 1041)" are 3 trials for "Male" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Centro Investigación del Cáncer James Lind ( Site 1041)". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centro Investigación del Cáncer James Lind ( Site 1041), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Investigación del Cáncer James Lind ( Site 1041), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Centro Investigación del Cáncer James Lind ( Site 1041) has several departments that took part in Clinical trials: "James Lind Centro de Investigación Del Cáncer" - 4 trials